Beam Therapeutics reports Q3 2026 financial results, updates on base editing platform

Beam Therapeutics reported its third quarter 2026 financial results on November 3, 2026, providing updates on its base editing platform and progress across four clinical programs as it advances its portfolio of genetic medicines.

Detected & updated continuously · Source: Nebula